Green Cross Cell’s Immune Cell-LC designated as orphan drug for brain tumor from FDA
Green Cross Cell(Duk-Joo Lee), a cell therapy company, announced on the 17th that their ‘Immune Cell-LC’ was designated as orphan drug from the U.S. FDA on the 17th.
Immune Cell-LC acquired approval as an anticancer drug for liver cancer from the Ministry of Food and Drug Safety in 2007 and has ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
